Latest News in the pharma Industry

Research & Development

Capillary Film Technology Receives £1 Million Funding to Develop a Point-of-Care Acute Coronary Syndrome Diagnostic

Capillary Film Technology Receives £1 Million Funding to Develop a Point-of-Care Acute Coronary Syndrome Diagnostic

9 Dec 2014

Read more 
Medications for Patients with First-Episode Psychosis May Not Meet Guidelines

Medications for Patients with First-Episode Psychosis May Not Meet Guidelines

9 Dec 2014

Read more 
SetPoint Announces First Trial of Bioelectronic Therapy to Treat Crohn’s Disease

SetPoint Announces First Trial of Bioelectronic Therapy to Treat Crohn’s Disease

5 Dec 2014

Read more 
BioVersys and Enamine to Extend Drug Discovery Collaboration to Address Multidrug-Resistant Bacterial Infections

BioVersys and Enamine to Extend Drug Discovery Collaboration to Address Multidrug-Resistant Bacterial Infections

2 Dec 2014

Read more 
Eli Lilly and Company and AstraZeneca Initiate Pivotal Clinical Trial for Patients with Early Alzheimer's Disease

Eli Lilly and Company and AstraZeneca Initiate Pivotal Clinical Trial for Patients with Early Alzheimer's Disease

1 Dec 2014

Read more 
Hovione Files its First Investigational New Drug Application with the FDA

Hovione Files its First Investigational New Drug Application with the FDA

28 Nov 2014

Read more 
NIAID/GSK Experimental Ebola Vaccine Appears Safe, Prompts Immune Response

NIAID/GSK Experimental Ebola Vaccine Appears Safe, Prompts Immune Response

28 Nov 2014

Read more 
FDA Approves Valeant Pharmaceuticals' Onexton Gel for the Treatment of Acne Vulgaris

FDA Approves Valeant Pharmaceuticals' Onexton Gel for the Treatment of Acne Vulgaris

27 Nov 2014

Read more 
Latest Antibiotic for Clostridium Difficile Significantly Reduces Recurrence of the Infection by 74% Versus Standard of Care

Latest Antibiotic for Clostridium Difficile Significantly Reduces Recurrence of the Infection by 74% Versus Standard of Care

26 Nov 2014

Read more 
BMS  Receives Complete Response Letter from FDA for Daclatasvir, an Investigational Treatment for Hepatitis C

BMS Receives Complete Response Letter from FDA for Daclatasvir, an Investigational Treatment for Hepatitis C

26 Nov 2014

Read more 
NTU Develops Novel 2-in-1 Biomarker and Drug Delivery System

NTU Develops Novel 2-in-1 Biomarker and Drug Delivery System

26 Nov 2014

Read more 
Computer Model Sets New Precedent in Drug Discovery

Computer Model Sets New Precedent in Drug Discovery

25 Nov 2014

Read more